Fundación de Investigación

Last updated: 30.10.2015

fdi logo

Fundación de Investigación (FDI) is a first rate research site with state-of-the-art facilities and medical care clinics with access to a viable patient population for research trials. We have a database of normal volunteers and the capability to conduct clinical trials at all stages of drug development, from First-in-Man, Proof of Concept (POC), to Phase 1 to Phase 3 studies. We also conduct selected post-approval or post-marketing Phase 4 studies, when there is interest in obtaining additional information, or to analyze the efficacy and safety of a particular drug in special populations. We have conducted hundredths of clinical trials in multiple therapeutic areas: Infectious Diseases as hepatitis C, hepatitis B, Influenza, and Herpes Zoster; Hematology and Oncology, all types of Cancers including Acute and Chronic Leukemia; Vaccines; Metabolic Syndrome manifestations as Diabetes Mellitus, Arterial Hypertension, Nonalcoholic steatohepatitis (NASH) and Obesity; Rheumatology and Immune Diseases as Rheumatoid Arthritis, Systemic Erythematous Lupus, Osteoarthritis and Gout; Respiratory Diseases as Asthma, Chronic Obstructive Pulmonary Disease and others. Our site’s advanced technology includes a phase I unit and an in-house bio-analytical laboratory.

Our 30-bed Phase I Unit is the only one in the Caribbean and one of the few in South America. Our Phase I unit has state-of-the-art monitoring technology that includes remote telemetry and sophisticated software designed to manage phase I trials. Our phase I unit’s experienced staff and facilities allow the trials to be conducted without interruption 7 days a week.

Contact details

Avenida Muñoz Rivera 998
Rio Piedras, PR 00927

USA

T: (787) 722-1428

F: (787) 721-6098

www.fundaciondeinvestigacion.com

Interviews

Related

We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here